Cann Global re-lists and starts afresh in medical marijuana space
Cann Global Ltd (ASX:CGB) managing director Sholom Feldman updates Proactive Investors on the company’s exciting transformation from a mining company into the medical cannabis space.
The company has recently been relisted on the Australian Stock Exchange and has raised revenue to help support the new focus, strategy and growth.
Impressive results are already being seen in the company’s hemp food division, medical research with a Israeli University and a joint venture with international health and wellness company Pharmacan.
Quick facts: Cann Global Ltd
Market Cap: $65.69 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE